Second-line chemotherapy in patients with small-cell lung cancer: Phase II trial of ZD0473

被引:0
|
作者
Schiller, J [1 ]
Bonomi, G [1 ]
Modiano, M [1 ]
Bonomi, P [1 ]
Cornett, P [1 ]
Kelly, K [1 ]
Koehler, M [1 ]
机构
[1] Univ Wisconsin, Ctr Comprehens Canc, Madison, WI 53706 USA
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
ZD0473 is a new generation platinum drug designed to deliver an extended spectrum of antitumour activity and overcome platinum resistance mechanisms. We present interim results from a Phase II trial of ZD0473 in patients with small-cell lung cancer (SCLC).
引用
收藏
页码:335 / 339
页数:5
相关论文
共 50 条
  • [1] Phase II trial of ZD0473 as second-line therapy in mesothelioma
    Giaccone, G
    O'Brien, MER
    Byrne, MJ
    Bard, M
    Kaukel, E
    Smit, B
    EUROPEAN JOURNAL OF CANCER, 2002, 38 : S19 - S24
  • [2] ZD0473 as second-line therapy in non-small cell lung cancer: A Phase II study
    Treat, J
    Huang, C
    Damanjov, N
    Jahenzeb, M
    Edelman, M
    Koehler, M
    LUNG CANCER: CURRENT TOPICS, 2001, : 341 - 344
  • [3] ZD0473 phase in monotherapy trial in second-line ovarian cancer
    Gore, M
    Atkinson, RJ
    Dirix, L
    Rischin, D
    Beale, P
    Harnet, P
    Hacking, D
    Cure, H
    Cosaert, J
    BRITISH JOURNAL OF CANCER, 2001, 85 : 57 - 57
  • [4] ZD0473 monotherapy as first-line treatment for non-small cell lung cancer: A Phase II clinical trial
    Quoix, E
    Cosaert, J
    Moro, D
    LUNG CANCER: CURRENT TOPICS, 2001, : 329 - 333
  • [5] Phase II trial of second-line bendamustine chemotherapy in relapsed small cell lung cancer patients
    Schmittel, Alexander
    Knoedler, Maren
    Hortig, Patricia
    Schulze, Karsten
    Thiel, Eckhard
    Keilholz, Ulrich
    LUNG CANCER, 2007, 55 (01) : 109 - 113
  • [6] Gemcitabine and Paclitaxel Combination as Second-Line Chemotherapy in Patients With Small-Cell Lung Cancer: A Phase II Study
    Dazzi, Claudio
    Cariello, Anna
    Casanova, Claudia
    Verlicchi, Alberto
    Montanari, Marco
    Papiani, Giorgio
    Freier, Eva
    Mazza, Valentina
    Milandri, Carlo
    Gamboni, Alessandro
    Papi, Maximilian
    Leoni, Maurizio
    Cruciani, Giorgio
    Vertogen, Bernadette
    CLINICAL LUNG CANCER, 2013, 14 (01) : 28 - 33
  • [7] Second-line chemotherapy for small-Cell Lung Cancer (SCLC)
    Kim, Young Hak
    Mishima, Michiaki
    CANCER TREATMENT REVIEWS, 2011, 37 (02) : 143 - 150
  • [8] Phase II Study of Picoplatin As Second-Line Therapy for Patients With Small-Cell Lung Cancer
    Eckardt, John R.
    Bentsion, Dimitri L.
    Lipatov, Oleg N.
    Polyakov, Igor S.
    MacKintosh, Frederick R.
    Karlin, David A.
    Baker, Gizelle S.
    Breitz, Hazel B.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (12) : 2046 - 2051
  • [9] A phase II trial of ZD0473 in platinum-pretreated ovarian cancer
    Gore, ME
    Atkinson, RJ
    Thomas, H
    Cure, H
    Rischin, D
    Beale, P
    Bougnoux, P
    Dirix, L
    Smit, WM
    EUROPEAN JOURNAL OF CANCER, 2002, 38 (18) : 2416 - 2420
  • [10] Phase II study of doxorubicin and paclitaxel as second-line chemotherapy of small-cell lung cancer - A Hoosier Oncology Group Trial
    Sonpavde, G
    Ansari, R
    Walker, P
    Sciortino, DF
    Gabrys, GT
    Murdock, A
    Gonin, R
    Einhorn, LH
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2000, 23 (01): : 68 - 70